GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,110
-120 (-1.17%)
Jul 24, 2026, 3:30 PM KST

GemVax&KAEL Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
87,41581,53162,69272,20975,80460,371
Revenue Growth
44.89%30.05%-13.18%-4.74%25.56%-8.06%
Gross Profit
35,76734,81619,48225,93821,72218,667
Operating Income
5,9843,793-38,337-7,868-3,929-2,450
Net Income
-3,945-11,337-87,219-27,177-19,60412,058
Earnings Per Share
-93.83-274.98-2202.00-691.00-497.32280.00
EPS Growth
-----571.14%

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
28,65522,7787,27520,70042,81235,498
Total Debt
58,59160,89373,99014,5437,4408,218
Net Cash (Debt)
-29,935-38,115-66,7156,15735,37227,280
Net Cash Growth
----82.59%29.66%-31.49%
Net Cash Per Share
-712.10-924.51-1684.35156.47897.33633.48

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-639.571,108-28,3693,566-2,955-3,467
Capital Expenditures
-1,174-997.19-3,489-8,461-9,090-6,874
Free Cash Flow
-1,814111.3-31,858-4,895-12,045-10,341
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
40.92%42.70%31.08%35.92%28.66%30.92%
Operating Margin
6.85%4.65%-61.15%-10.90%-5.18%-4.06%
Pretax Margin
-4.01%-14.02%-140.05%-37.87%-25.86%19.97%
Profit Margin
-4.51%-13.91%-139.12%-37.64%-25.86%19.97%
FCF Margin
-2.08%0.14%-50.82%-6.78%-15.89%-17.13%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----57.60
P/FCF Ratio
-11038.79----
PS Ratio
5.0815.079.377.256.1411.50